Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RPRX | BIIB | BNTX | ||
| Company | Royalty Pharma Plc Cl A | Biogen Inc | Biontech Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 40.64 | 181.70 | 98.28 | ||
| High | 41.24 | 186.48 | 99.88 | ||
| Low | 40.64 | 181.70 | 97.80 | ||
| Latest | 41.26 | 184.93 | 100.89 | ||
| Change | +0.61 | +2.32 | +2.80 | ||
| % Change | +1.50% | +1.27% | +2.85% | ||
| Volume | 2,168,729 | 932,281 | 524,831 | ||
| 20-Day Average Volume | 3,795,813 | 2,295,107 | 1,153,241 | ||
| Previous Close | 40.65 | 182.61 | 98.09 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 38.97 | 175.78 | 94.83 | ||
| 20-Day Raw Stochastic | 94.07% | 88.09% | 95.21% | ||
| 20-Day Relative Strength | 64.31 | 64.36 | 54.96 | ||
| Weighted Alpha | +38.57 | +37.65 | -15.91 | ||
| Today's Opinion | 100% Buy | 100% Buy | 64% Sell | ||
| Previous Opinion | 100% Buy | 100% Buy | 88% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.17% since 12/30/25 | +4.50% since 12/30/25 | +4.39% since 12/30/25 | ||
| Low | 38.29 on 01/02/26 | 171.61 on 01/05/26 | 94.86 on 12/31/25 | ||
| High | 41.21 on 01/07/26 | 186.48 on 01/07/26 | 99.88 on 01/07/26 | ||
| 1-Month | |||||
| %Chg | +3.21% since 12/05/25 | +1.68% since 12/05/25 | +3.34% since 12/05/25 | ||
| Low | 37.83 on 12/16/25 | 168.56 on 12/18/25 | 91.11 on 12/18/25 | ||
| High | 41.21 on 01/07/26 | 186.48 on 01/07/26 | 99.88 on 01/07/26 | ||
| 3-Month | |||||
| %Chg | +13.59% since 10/07/25 | +21.11% since 10/07/25 | -6.22% since 10/07/25 | ||
| Low | 35.23 on 10/13/25 | 138.00 on 10/30/25 | 91.11 on 12/18/25 | ||
| High | 41.24 on 11/06/25 | 186.48 on 01/07/26 | 113.39 on 11/12/25 | ||
| 6-Month | |||||
| %Chg | +15.21% since 07/07/25 | +41.66% since 07/07/25 | -9.62% since 07/07/25 | ||
| Low | 34.08 on 09/08/25 | 121.05 on 07/21/25 | 90.12 on 09/12/25 | ||
| High | 41.24 on 11/06/25 | 186.48 on 01/07/26 | 115.54 on 07/25/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 22,431,468 | 26,086,550 | 21,772,850 | ||
| Shares Outstanding, K | 577,238 | 146,702 | 225,182 | ||
| Annual Sales | 2,263,580,000 | 9,675,900,000 | 2,976,970,000 | ||
| Annual Net Income | 858,980,000 | 1,632,200,000 | -719,920,000 | ||
| Last Quarter Sales | 609,290,000 | 2,534,700,000 | 1,775,440,000 | ||
| Last Quarter Net Income | 288,220,000 | 466,500,000 | -33,550,000 | ||
| 60-Month Beta | 0.43 | 0.13 | 1.40 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.17 on 11/05/25 | 4.81 on 10/30/25 | -0.14 on 11/03/25 | ||
| Latest Earnings Date | 02/10/26 | 02/11/26 | 03/09/26 | ||
| Most Recent Dividend | 0.220 on 11/14/25 | N/A | 3.084 on 06/02/22 | ||
| Next Ex-Dividends Date | 11/14/25 | N/A | 06/02/22 | ||
| Ratios | |||||
| Price/Earnings ttm | 8.55 | 10.51 | 0.00 | ||